Literature DB >> 9631146

Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users.

D R Gibson1, J McCusker, M Chesney.   

Abstract

OBJECTIVE: To consider evidence for the effectiveness of psychosocial interventions in reducing the risk of infection with HIV of injecting drug users.
METHOD: We reviewed 19 published studies of the effectiveness of individual counselling, HIV testing, group interventions, street outreach, and a 'social' intervention designed to change norms for safer behaviours.
RESULTS: Eight of 15 studies that examined behavioural outcomes provided evidence of the effectiveness of an experimental intervention, compared with a control or comparison group. In four of these studies, however, serious design limitations made results difficult to interpret. In the other four studies without design limitations, the success of the experimental interventions may have been due to their greater length and intensity as well as to having been conducted with stable and well-motivated populations. Nine of the 15 studies showed evidence of marked behaviorial changes in both experimental and comparison group(s), with the changes in many cases being sustained for upwards of 12 months.
CONCLUSIONS: A close examination of the evidence and competing hypotheses for the pattern of results suggests that participating in evaluation research may itself be a valuable intervention. Implications for the development of interventions include the potential efficacy of health risk assessment. Implications for evaluation of interventions include the need for developing unobtrusive measures and for assessing the impact of behavioural assessments. Despite the large behavioural changes reported in most of the studies, a substantial proportion of subjects receiving interventions reported unacceptably high levels of risk behaviours. New, more potent interventions are needed, such as those designed to change the norms of entire communities of drug users concerning safer injection and safer sex.

Entities:  

Mesh:

Year:  1998        PMID: 9631146     DOI: 10.1097/00002030-199808000-00015

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

1.  Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

Authors:  M G Schlumberger; J C Desenclos; G Papaevangelou; S C Richardson; R Ancelle-Park
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

2.  Sexual risk reduction among HIV-positive drug-using men who have sex with men.

Authors:  Thomas L Patterson; Shirley J Semple
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

Review 3.  Behavior change and health-related interventions for heterosexual risk reduction among drug users.

Authors:  Salaam Semaan; Don C Des Jarlais; Rob Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

4.  Conceptualizing the Influence of Social Agents of Behavior Change: A Meta-Analysis of the Effectiveness of HIV-Prevention Interventionists for Different Groups.

Authors:  Marta R Durantini; Dolores Albarracín; Amy L Mitchell; Allison N Earl; Jeffrey C Gillette
Journal:  Psychol Bull       Date:  2006-03       Impact factor: 17.737

Review 5.  Neurocognitive impact of antiretroviral treatment: thinking long-term.

Authors:  Megan E McPhail; Kevin R Robertson
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

6.  Increasing quality of life and reducing HIV burden: the PATH+ intervention.

Authors:  Michael B Blank; Michael Hennessy; Marlene M Eisenberg
Journal:  AIDS Behav       Date:  2014-04

7.  Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE study.

Authors:  Brent T Mausbach; Shirley J Semple; Steffanie A Strathdee; Jim Zians; Thomas L Patterson
Journal:  Drug Alcohol Depend       Date:  2006-12-19       Impact factor: 4.492

8.  The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.

Authors:  Allison J Applebaum; Laura C Reilly; Jeffrey S Gonzalez; Mark A Richardson; Catherine L Leveroni; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2009-06       Impact factor: 5.078

9.  Preventing HIV in injection drug users: choosing the best mix of interventions for the population.

Authors:  Amy R Wilson; James G Kahn
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

10.  HIV/hepatitis prevention in drug abuse treatment programs: guidance from research.

Authors:  James L Sorensen; Carmen L Masson; David C Perlman
Journal:  Sci Pract Perspect       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.